EVENTS | VIEW CALENDAR
Congress proposes big cuts to FDA budget
WASHINGTON, D.C.—In an attempt to address what they call America's "destructive spending pattern," members of the U.S. House Appropriations Committee have proposed a $285 million cut to the U.S. Food and Drug Administration's (FDA) 2012 spending bill.
"As is the goal of all our appropriations bills this year, this legislation reflects hard decisions to cut lower priority programs, reduce spending in programs that can be scaled back, and target funds where they are needed most so that our nation continues on the path to fiscal recovery," said Rep. Harold Rogers, R-Ky., and chairman of the committee.
The proposed budget, which the committee voted on by voice in late May, would bring the FDA's total budget for next year to $3.7 billion. The bill would also set the FDA's appropriations level at $2.2 billion, about $300 million below current levels and almost $600 million below President Barack Obama's request.
In addition to the funding it collects from Congress, the FDA also receives funding from the pharmaceutical and medical device industries, which pay the agency to review new product applications.
Some industry and consumer groups have been pushing for an increase in FDA spending since the end of the Bush administration, in a response to high-profile drug contamination cases.
The bill was expected to pass as this issue went to press.